Mr. Sompijit Chaichanajarak During 2020, four directors and executives of Nusasiri Public Company Limited (“NUSA”), namely (1) Mrs. Siriya Thepcharoen, (2) Mr. Visanu Thepcharoen, (3) Mr. Sompijit

Mr. Nontawat Dhanasuwiwath During 2020, four directors and executives of Nusasiri Public Company Limited (“NUSA”), namely (1) Mrs. Siriya Thepcharoen, (2) Mr. Visanu Thepcharoen, (3) Mr. Sompijit

Ms. Varinborn Chantarojvanich During 2020, four directors and executives of Nusasiri Public Company Limited (“NUSA”), namely (1) Mrs. Siriya Thepcharoen, (2) Mr. Visanu Thepcharoen, (3) Mr. Sompijit

Mrs. Chomsuda Rungruangnavarat During 2020, four directors and executives of Nusasiri Public Company Limited (“NUSA”), namely (1) Mrs. Siriya Thepcharoen, (2) Mr. Visanu Thepcharoen, (3) Mr. Sompijit

(10) Miss Achiraya Kiatthayakorn (formerly Miss Ganpaorn Kieattayakorn), colluded to manipulate the stock price of (1) SCI Electric Public Company Limited (SCI) between 25 November 2019 and 12 December

were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which

Debt to Equity Conversion Scheme”). Since the said conversion price is 35.50 percent lower than the market price, such offering of the newly issued ordinary shares of the Company is an offering of shares

transaction under the Notification of the Capital Market Supervisory Board No. ThorJor. 21/2551 List of shareholders of Modern Pharma Company Limited as of 5th May 2020 before entering into the transaction: No

Public Company Limited and its subsidiaries, would like to present the Management Discussion and Analysis (MD&A) of Q1/2020 as follows: Management Discussion and Analysis (MD&A) Patum Rice Mill and Granary

.2542 (1999), and Clause 5 (1) in conjunction with Clause 16, Clause 17, Clause 18, Clause 19, Clause 22 (3), Clause 23 and Clause 24 of the Notification of the Capital Market Supervisory Board No. Tor